How to Reduce Off-Target Effects of Genome Editing

There are several strategies to lower the predicted frequency of off-target events, many of which can be combined to lower them even further. During this segment, Accenture’s Eric Clark and Caribou Biosciences’ Steve Kanner share strategies to reduce off-target genome editing as well as ways to limit unplanned effects of on-target gene editing. They also cover the diseases that are suitable targets for genome editing.